Open Access

[Retracted] lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection

  • Authors:
    • Jiansong Wu
    • Qiang Niu
    • Jie Yuan
    • Xiaodan Xu
    • Liuxia Cao
  • View Affiliations

  • Published online on: May 6, 2025     https://doi.org/10.3892/ol.2025.15075
  • Article Number: 329
  • Copyright : © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

July-2025
Volume 30 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu J, Niu Q, Yuan J, Xu X and Cao L: [Retracted] lncRNA‑CD160 decreases the immunity of CD8<sup>+</sup> T cells through epigenetic mechanisms in hepatitis B virus infection. Oncol Lett 30: 329, 2025.
APA
Wu, J., Niu, Q., Yuan, J., Xu, X., & Cao, L. (2025). [Retracted] lncRNA‑CD160 decreases the immunity of CD8<sup>+</sup> T cells through epigenetic mechanisms in hepatitis B virus infection. Oncology Letters, 30, 329. https://doi.org/10.3892/ol.2025.15075
MLA
Wu, J., Niu, Q., Yuan, J., Xu, X., Cao, L."[Retracted] lncRNA‑CD160 decreases the immunity of CD8<sup>+</sup> T cells through epigenetic mechanisms in hepatitis B virus infection". Oncology Letters 30.1 (2025): 329.
Chicago
Wu, J., Niu, Q., Yuan, J., Xu, X., Cao, L."[Retracted] lncRNA‑CD160 decreases the immunity of CD8<sup>+</sup> T cells through epigenetic mechanisms in hepatitis B virus infection". Oncology Letters 30, no. 1 (2025): 329. https://doi.org/10.3892/ol.2025.15075